Atreca Inc (BCEL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

835 INDUSTRIAL ROAD, SAN CARLOS, CA 94070

Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca's platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as its lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients.

Data as of 2021-10-09 10:40:41 -0400
Market Cap175.038 Million Shares Outstanding30.179 Million Avg 30-day Volume315.516 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.09 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.13495 52-week High/Low20.29 / 4.8 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -8.4514
Data provided by IEX Cloud
View SEC Filings from BCEL instead.

View recent insider trading info

Funds Holding BCEL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCEL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

30 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SERAFINI TITO CHIEF STRATEGY OFFICER

  • Officer
  • Director
669,950 2021-09-27 9

CROSS HERB CHIEF FINANCIAL OFFICER

  • Officer
42,200 2021-09-09 2

ORWIN JOHN A PRESIDENT & CEO

  • Officer
  • Director
121,400 2021-09-09 2

COURTNEY PHILLIPS GENERAL COUNSEL & SECRETARY

  • Officer
35,500 2021-09-09 2

BRADY STEPHEN R

  • Director
0 2021-07-14 2

MA STACEY

  • Director
0 2021-07-14 2

BALL KRISTINE M

  • Director
12,000 2021-06-09 1

ATWOOD BRIAN G

  • Director
12,000 2021-06-09 2

BERGER FRANKLIN M

  • Director
12,000 2021-06-09 1

ROLFE LINDSEY

  • Director
12,000 2021-06-09 1

LACEY DAVID L.

  • Director
12,000 2021-06-09 1

ROBINSON WILLIAM HEWITT

  • Director
12,000 2021-06-09 6

GREENBERG NORMAN MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
41,928 2021-03-17 10

DECKER LISA LYNN CHIEF BUSINESS OFFICER

  • Officer
0 2021-01-27 1

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
0 2020-07-20 0

CAVET GUY CHIEF TECHNICAL OFFICER

  • Officer
87,758 2020-02-25 0

STEINMAN LAWRENCE

  • Director
258,405 2019-06-24 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
No longer subject to file 2019-06-24 0

BILL & MELINDA GATES FOUNDATION

1,396,644 2019-06-24 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

  • 10% Owner
No longer subject to file 2019-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SERAFINI TITO - Director - Officer CHIEF STRATEGY OFFICER by the serafini/postner revocable trust

2021-09-28 17:37:38 -0400 2021-09-27 S 30,000 $6.58 d 273,875 indirect yes 8.1597 3.125 8.1597 2 0.0 1

SERAFINI TITO - Director - Officer CHIEF STRATEGY OFFICER by the serafini/postner irrevocable remainder trust

2021-09-28 17:37:38 -0400 2021-09-20 G 50,000 a 50,000 indirect 8.1597 3.125 8.1597 2 0.0 1

SERAFINI TITO - Director - Officer CHIEF STRATEGY OFFICER by the serafini/postner revocable trust

2021-09-28 17:37:38 -0400 2021-09-20 G 50,000 d 303,875 indirect 8.1597 3.125 8.1597 2 0.0 1

CROSS HERB - Officer CHIEF FINANCIAL OFFICER

2021-09-13 21:45:13 -0400 2021-09-09 A 42,200 a 42,200 direct -1.2903 8.5484 8.5484 6 -1.4516 3

ORWIN JOHN A - Director - Officer PRESIDENT & CEO

2021-09-13 21:46:26 -0400 2021-09-09 A 115,400 a 121,400 direct -1.2903 8.5484 8.5484 6 -1.4516 3

SERAFINI TITO - Director - Officer CHIEF STRATEGY OFFICER

2021-09-13 21:42:29 -0400 2021-09-09 A 42,200 a 42,200 direct -1.2903 8.5484 8.5484 6 -1.4516 3

COURTNEY PHILLIPS - Officer GENERAL COUNSEL & SECRETARY

2021-09-13 21:44:08 -0400 2021-09-09 A 35,500 a 35,500 direct -1.2903 8.5484 8.5484 6 -1.4516 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATRECA INC - A BCEL 2021-10-15 22:15:04 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 21:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 21:15:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 20:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 20:15:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 19:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 19:15:04 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 18:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 18:15:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 17:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 17:15:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 16:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 16:15:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 15:45:03 UTC -0.6181 0.6881 750000
ATRECA INC - A BCEL 2021-10-15 15:15:03 UTC -0.6181 0.6881 700000
ATRECA INC - A BCEL 2021-10-15 14:45:02 UTC -0.6858 0.7558 700000
ATRECA INC - A BCEL 2021-10-15 14:15:03 UTC -0.6858 0.7558 700000
ATRECA INC - A BCEL 2021-10-15 13:45:03 UTC -0.6858 0.7558 700000
ATRECA INC - A BCEL 2021-10-15 13:15:03 UTC -0.6858 0.7558 700000
ATRECA INC - A BCEL 2021-10-15 12:45:03 UTC -0.6858 0.7558 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund BCEL -29.0 shares, $-479.95 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund BCEL -1.0 shares, $-16.55 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund BCEL -42.0 shares, $-695.1 2020-03-31 N-PORT

Elevate your investments